Microbot Medical (NASDAQ:MBOT - Get Free Report) is anticipated to announce its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.
Microbot Medical Price Performance
MBOT stock traded up $0.04 on Friday, reaching $1.70. 1,157,744 shares of the company were exchanged, compared to its average volume of 1,761,414. The firm has a market capitalization of $59.06 million, a PE ratio of -2.12 and a beta of 1.60. Microbot Medical has a 12 month low of $0.82 and a 12 month high of $3.38. The stock's fifty day moving average price is $1.76 and its 200 day moving average price is $1.29.
Analyst Ratings Changes
Separately, HC Wainwright upped their price objective on shares of Microbot Medical from $7.00 to $9.00 and gave the company a "buy" rating in a research report on Friday, January 24th.
Read Our Latest Stock Analysis on MBOT
Microbot Medical Company Profile
(
Get Free Report)
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Further Reading
Before you consider Microbot Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microbot Medical wasn't on the list.
While Microbot Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
